Literature DB >> 23071334

Crystal structure of the human PRMT5:MEP50 complex.

Stephen Antonysamy1, Zahid Bonday, Robert M Campbell, Brandon Doyle, Zhanna Druzina, Tarun Gheyi, Bomie Han, Louis N Jungheim, Yuewei Qian, Charles Rauch, Marijane Russell, J Michael Sauder, Stephen R Wasserman, Kenneth Weichert, Francis S Willard, Aiping Zhang, Spencer Emtage.   

Abstract

Protein arginine methyltransferases (PRMTs) play important roles in several cellular processes, including signaling, gene regulation, and transport of proteins and nucleic acids, to impact growth, differentiation, proliferation, and development. PRMT5 symmetrically di-methylates the two-terminal ω-guanidino nitrogens of arginine residues on substrate proteins. PRMT5 acts as part of a multimeric complex in concert with a variety of partner proteins that regulate its function and specificity. A core component of these complexes is the WD40 protein MEP50/WDR77/p44, which mediates interactions with binding partners and substrates. We have determined the crystal structure of human PRMT5 in complex with MEP50 (methylosome protein 50), bound to an S-adenosylmethionine analog and a peptide substrate derived from histone H4. The structure of the surprising hetero-octameric complex reveals the close interaction between the seven-bladed β-propeller MEP50 and the N-terminal domain of PRMT5, and delineates the structural elements of substrate recognition.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23071334      PMCID: PMC3497828          DOI: 10.1073/pnas.1209814109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  43 in total

1.  The FCP1 phosphatase interacts with RNA polymerase II and with MEP50 a component of the methylosome complex involved in the assembly of snRNP.

Authors:  Paolo Licciardo; Stefano Amente; Luca Ruggiero; Maria Monti; Piero Pucci; Luigi Lania; Barbara Majello
Journal:  Nucleic Acids Res       Date:  2003-02-01       Impact factor: 16.971

2.  Structural insights into protein arginine symmetric dimethylation by PRMT5.

Authors:  Litao Sun; Mingzhu Wang; Zongyang Lv; Na Yang; Yingfang Liu; Shilai Bao; Weimin Gong; Rui-Ming Xu
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-05       Impact factor: 11.205

3.  A novel WD repeat protein component of the methylosome binds Sm proteins.

Authors:  Westley J Friesen; Anastasia Wyce; Sergey Paushkin; Linda Abel; Juri Rappsilber; Matthias Mann; Gideon Dreyfuss
Journal:  J Biol Chem       Date:  2001-12-26       Impact factor: 5.157

4.  Symmetric dimethylation of H3R2 is a newly identified histone mark that supports euchromatin maintenance.

Authors:  Valentina Migliori; Julius Müller; Sameer Phalke; Diana Low; Marco Bezzi; Wei Chuen Mok; Sanjeeb Kumar Sahu; Jayantha Gunaratne; Paola Capasso; Christian Bassi; Valentina Cecatiello; Ario De Marco; Walter Blackstock; Vladimir Kuznetsov; Bruno Amati; Marina Mapelli; Ernesto Guccione
Journal:  Nat Struct Mol Biol       Date:  2012-01-08       Impact factor: 15.369

5.  Methylation of ribosomal protein S10 by protein-arginine methyltransferase 5 regulates ribosome biogenesis.

Authors:  Jinqi Ren; Yaqing Wang; Yuheng Liang; Yongqing Zhang; Shilai Bao; Zhiheng Xu
Journal:  J Biol Chem       Date:  2010-02-16       Impact factor: 5.157

6.  delta-N-methylarginine is a novel posttranslational modification of arginine residues in yeast proteins.

Authors:  P Zobel-Thropp; J D Gary; S Clarke
Journal:  J Biol Chem       Date:  1998-11-06       Impact factor: 5.157

7.  Protein arginine methyltransferase 5 suppresses the transcription of the RB family of tumor suppressors in leukemia and lymphoma cells.

Authors:  Li Wang; Sharmistha Pal; Saïd Sif
Journal:  Mol Cell Biol       Date:  2008-08-11       Impact factor: 4.272

8.  Human protein arginine methyltransferases in vivo--distinct properties of eight canonical members of the PRMT family.

Authors:  Frank Herrmann; Peter Pably; Carmen Eckerich; Mark T Bedford; Frank O Fackelmayer
Journal:  J Cell Sci       Date:  2009-02-10       Impact factor: 5.285

Review 9.  Protein arginine methylation in mammals: who, what, and why.

Authors:  Mark T Bedford; Steven G Clarke
Journal:  Mol Cell       Date:  2009-01-16       Impact factor: 17.970

10.  Expression and function of androgen receptor coactivator p44/Mep50/WDR77 in ovarian cancer.

Authors:  Martin Ligr; Ruzeen Rohintan Patwa; Garrett Daniels; Lorraine Pan; Xinyu Wu; Yirong Li; Liantian Tian; Zhenxing Wang; Ruliang Xu; Jingjing Wu; Fan Chen; Jinsong Liu; Jian-Jun Wei; Peng Lee
Journal:  PLoS One       Date:  2011-10-13       Impact factor: 3.240

View more
  116 in total

Review 1.  Small Molecule Inhibitors of Protein Arginine Methyltransferases.

Authors:  Hao Hu; Kun Qian; Meng-Chiao Ho; Y George Zheng
Journal:  Expert Opin Investig Drugs       Date:  2016-02-16       Impact factor: 6.206

Review 2.  The PRMT5 arginine methyltransferase: many roles in development, cancer and beyond.

Authors:  Nicole Stopa; Jocelyn E Krebs; David Shechter
Journal:  Cell Mol Life Sci       Date:  2015-02-07       Impact factor: 9.261

Review 3.  PRMT7 as a unique member of the protein arginine methyltransferase family: A review.

Authors:  Kanishk Jain; Steven G Clarke
Journal:  Arch Biochem Biophys       Date:  2019-02-22       Impact factor: 4.013

Review 4.  An evolving understanding of nuclear receptor coregulator proteins.

Authors:  Christopher J Millard; Peter J Watson; Louise Fairall; John W R Schwabe
Journal:  J Mol Endocrinol       Date:  2013-11-07       Impact factor: 5.098

5.  LLY-283, a Potent and Selective Inhibitor of Arginine Methyltransferase 5, PRMT5, with Antitumor Activity.

Authors:  Zahid Q Bonday; Guillermo S Cortez; Michael J Grogan; Stephen Antonysamy; Ken Weichert; Wayne P Bocchinfuso; Fengling Li; Steven Kennedy; Binghui Li; Mary M Mader; Cheryl H Arrowsmith; Peter J Brown; Mohammad S Eram; Magdalena M Szewczyk; Dalia Barsyte-Lovejoy; Masoud Vedadi; Ernesto Guccione; Robert M Campbell
Journal:  ACS Med Chem Lett       Date:  2018-04-23       Impact factor: 4.345

Review 6.  Readers of histone methylarginine marks.

Authors:  Sitaram Gayatri; Mark T Bedford
Journal:  Biochim Biophys Acta       Date:  2014-02-28

7.  A selective inhibitor of PRMT5 with in vivo and in vitro potency in MCL models.

Authors:  Elayne Chan-Penebre; Kristy G Kuplast; Christina R Majer; P Ann Boriack-Sjodin; Tim J Wigle; L Danielle Johnston; Nathalie Rioux; Michael J Munchhof; Lei Jin; Suzanne L Jacques; Kip A West; Trupti Lingaraj; Kimberly Stickland; Scott A Ribich; Alejandra Raimondi; Margaret Porter Scott; Nigel J Waters; Roy M Pollock; Jesse J Smith; Olena Barbash; Melissa Pappalardi; Thau F Ho; Kelvin Nurse; Khyati P Oza; Kathleen T Gallagher; Ryan Kruger; Mikel P Moyer; Robert A Copeland; Richard Chesworth; Kenneth W Duncan
Journal:  Nat Chem Biol       Date:  2015-04-27       Impact factor: 15.040

8.  Glutathionylation Decreases Methyltransferase Activity of PRMT5 and Inhibits Cell Proliferation.

Authors:  Meiqi Yi; Yingying Ma; Yuling Chen; Chongdong Liu; Qingtao Wang; Haiteng Deng
Journal:  Mol Cell Proteomics       Date:  2020-08-31       Impact factor: 5.911

9.  Sirtuin 7-mediated deacetylation of WD repeat domain 77 (WDR77) suppresses cancer cell growth by reducing WDR77/PRMT5 transmethylase complex activity.

Authors:  Hao Qi; Xiaoyan Shi; Miao Yu; Boya Liu; Minghui Liu; Shi Song; Shuaiyi Chen; Junhua Zou; Wei-Guo Zhu; Jianyuan Luo
Journal:  J Biol Chem       Date:  2018-10-03       Impact factor: 5.157

10.  LKB1 regulates PRMT5 activity in breast cancer.

Authors:  Hanine Lattouf; Loay Kassem; Julien Jacquemetton; Ali Choucair; Coralie Poulard; Olivier Trédan; Laura Corbo; Mona Diab-Assaf; Nader Hussein; Isabelle Treilleux; Muriel Le Romancer
Journal:  Int J Cancer       Date:  2018-10-31       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.